Advertisement
Screener

Rocket Pharmaceuticals, Inc. (RCKT) ROE

Rocket Pharmaceuticals, Inc. (RCKT) ROE

  • 2026-06-30: ROE -4.68%.
  • 2026-03-31: ROE -87.96%.
  • 2025-12-31: ROE -80.49%.
  • 2025-09-30: ROE -76.80%.

Complete source-backed roe history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-4.68%
2026-03-31-87.96%
2025-12-31-80.49%
2025-09-30-76.80%
2025-06-30-72.64%
2025-03-31-62.61%
2024-12-31-55.86%
2024-09-30-78.26%
2024-06-30-65.84%
2024-03-31-56.47%
2023-12-31-49.86%
2023-09-30-46.69%
2023-06-30-61.67%
2023-03-31-51.70%
2022-12-31-45.31%
2022-09-30-54.28%
2022-06-30-49.46%
2022-03-31-41.16%
2021-12-31-37.18%
2021-09-30-38.24%
2021-06-30-33.65%
2021-03-31-32.34%
2020-12-31-27.74%
2020-09-30-40.79%
2020-06-30-33.33%
2020-03-31-28.84%
2019-12-31-25.15%
2019-09-30-36.54%
2019-06-30-32.81%
2019-03-31-44.40%
2018-12-31-38.40%
2018-09-30-37.50%
2018-06-30-28.32%
2018-03-31-18.84%
2017-12-31-124.91%
2017-09-3018.75%
2017-06-308.99%
2017-03-31-0.29%
2016-12-31-90.47%
2016-09-30-44.74%
2016-06-30-86.84%
2016-03-31-77.17%
2015-12-31-437.46%
2015-09-30-53.19%
2015-06-30-26.44%
2015-03-31-26.05%
2014-12-3118.49%

Annual ROE

DateROE
2025-12-31-80.49%
2024-12-31-55.86%
2023-12-31-49.86%
2022-12-31-45.31%
2021-12-31-37.18%
2020-12-31-27.74%
2019-12-31-25.15%
2018-12-31-38.40%
2017-12-31-126.16%
2016-12-31-90.47%
2015-12-31-437.46%
2014-12-3118.49%

Similar stocks

Stock NameCountryMarket CapPE Ratio
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01